University of Cincinnati, Department of Psychiatry and Behavioral Neuroscience
Welcome,         Profile    Billing    Logout  
 7 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DelBello, Melissa P
MOBILITY, NCT02515773: Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs

Completed
4
1565
US
Metformin, GLUCOPHAGE, healthy lifestyle intervention (LIFE), LIFE
Melissa Delbello, Patient-Centered Outcomes Research Institute
Bipolar Disorder
12/22
06/23
NCT04085172 / 2018-000821-29: A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)

Active, not recruiting
4
288
Europe, US
Guanfacine hydrochloride (TAK-503), Intuniv, SPD503, Atomoxetine hydrochloride, Placebo
Shire, Takeda Development Center Americas, Inc.
Attention Deficit Hyperactivity Disorder
06/27
06/27
NCT01908192 / 2017-001168-39: Adaptive Phase II Study to Evaluate the Safety & Efficacy of NaBen®

Terminated
2/3
60
US, RoW
NaBen®, Placebo
SyneuRx International (Taiwan) Corp
Schizophrenia
10/23
10/23
NCT02553161: Mechanism of Antidepressant-Related Dysfunctional Arousal in High-Risk Youth

Completed
N/A
214
US
Escitalopram, Lexapro, Cognitive behavioral Psychotherapy, CBT
University of Cincinnati, National Institute of Mental Health (NIMH)
Depression, Anxiety, Bipolar Disorder
07/22
12/22
IGNITE, NCT04348604: Improving Adherence in Adolescents and Young Adults With Bipolar Disorder

Completed
N/A
36
US
Customized Adherence Enhancement for Adolescents and Young Adults (CAE-AYA), Enhanced Treatment as Usual (ETAU)
Case Western Reserve University
Bipolar Disorder
09/23
09/23
McNamara, Robert
NERF, NCT02478788: Neuroimaging Study of Risk Factors for Adolescent Bipolar Disorder

Completed
4
153
US
mixed amphetamine salts-extended release (MAS-XR), AdderallXR, Placebo
University of Cincinnati, National Institute of Mental Health (NIMH)
Attention Deficit Hyperactivity Disorder
08/22
12/22
EPO-TRAUMA, NCT04588311: ErythroPOietin Alfa to Prevent Mortality and Reduce Severe Disability in Critically Ill TRAUMA Patients

Recruiting
3
2500
Europe, RoW
Epoetin Alfa 40000 UNT/ML, Eprex, Binocrit, Sodium Chloride 0.9%, Placebo, Saline
Australian and New Zealand Intensive Care Research Centre, University College Dublin, Medical Research Institute of New Zealand, Medical Research Future Fund, Health Research Board, Ireland, Health Research Council, New Zealand, Irish Critical Care Clinical Trials Network, ANZICS Clinical Trials Group, Monash University
Trauma, Traumatic Injury, Traumatic Brain Injury, Wounds and Injuries, Penetrating Injury, Blunt Injury, Major Trauma, Multiple Trauma
12/25
12/25
McLaughlin, Laura
No trials found
Fleischer, Leah
No trials found

Download Options